Effect on quality of life with a new insulin injection device in elderly patients with diabetes mellitus type 2

Journal of Diabetes and its Complications

Volumn 18, Issue 4, 2004, Pages 216-219

  De Luis, D A ^a   Aller, R ^a   Cuellar, L ^a   Terroba, M C ^a   Ovalle, H F ^a   Izaola, O ^a   Romero, E ^a  

^a UNIVERSITY OF VALLADOLID   (Spain)

Author keywords

Elderly patients; Insulin injection device; Type 2 diabetes mellitus

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BIOSAFETY; BLOOD GLUCOSE MONITORING; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DEVICE; DOSE RESPONSE; DRUG EFFICACY; ELDERLY CARE; FEMALE; GLUCOSE BLOOD LEVEL; HOME CARE; HUMAN; HYPOGLYCEMIA; INJECTION; MALE; MEAL; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT SATISFACTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; QUESTIONNAIRE; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME;

AGED; AGING; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; FEMALE; FOOD; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INJECTIONS; INSULIN; MALE; MIDDLE AGED; PATIENT SATISFACTION; PROSPECTIVE STUDIES; QUALITY OF LIFE;

EID: 2942644150     PISSN: 10568727     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1056-8727(03)00089-8     Document Type: Article

References (13)

1. Barnett A. Tablet and insulin therapy in type 2 diabetes in the elderly. Journal of the Royal Society of Medicine. 87:1994;612-614
2. Bashoff E., Beaser R. Insulin therapy and the reluctant patient. Postgraduate Medicine. 97:1995;86-90
3. Berger A.S., Saubrey N., Kühl C., Villumsen J. Clinical experience with a new device that will be simplify insulin injections. Diabetes Care. 8:1985;73-76
4. Coscelli C., Lostia S., Lunetta M. Safety, efficacy, acceptability of a pre-filled insulin pen in diabetic patients over 60 years old. Diabetes Research and Clinical Practice. 28:1995;173-177
5. Fox C., McKinnon C., Wall A., Lawton S.A. Ability to handle, and patient preference for, insulin delivery devices in visually impaired patients with type 2 diabetes. Practical Diabetes International. 19:2002;104-107
6. Lewis K.S., Bradley C., Knight G., Boultin A.J.M., Ward J.D. A measure of treatment satisfaction designed specifically for people with insulin-dependent diabetes. Diabetic Medicine. 5:1988;235-242
7. Paton J.S., Wilson M., Ireland J.T., Reith S.B.M. Convenient pocket insulin syringe. Lancet. 1:1981;189-190
8. Petersen R.C., Smith G., Kokman E. Memory function in normal aging. Neurology. 42:1992;396-401
9. Puxty J., Hunter D., Burr W. Accuracy of insulin injection in elderly patients. British Medical Journal. 287:1983;1726
10. Reaven G.M., Thompson L.W., Nahum D., Haskins E. Relationship between hypeglycaemia and cognitive function in older NIDDM patients. Diabetes Care. 13:1990;16-21
11. Shelmet J.J., Lyness W.H. Resources utilization and patient preference with Innolet vs vial and syringe in elderly subjects with diabetes mellitus. Diabetes. 51(Suppl. 2):2002;245
12. UK Prospective Diabetes Study (UKPDS) Group Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and the risks of complications in patients with type 2 diabetes (UKPDS33). Lancet. 352:1998;837-853
13. Walters D.P., Smith P.A., Marteau T.M., Brimble A., Borthwick L.J. Experience with NovoPen, an injection device using cartridged insulin, for diabetic patients. Diabetic Medicine. 2:1985;496-498